Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 5,037,854 | +126,315 | 109,036 | 182,924 | 25.90% | +73,888 |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | 49,144 | 61,218 | 8.67% | +12,074 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 7,820 | 19,129 | 2.71% | +11,309 |
| Oculis Holding AG | 322,500 | 641,022 | +318,522 | 5,670 | 12,801 | 1.81% | +7,132 |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | 40,330 | 46,750 | 6.62% | +6,421 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 8,275 | 13,043 | 1.85% | +4,768 |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 137,753 | +137,753 | 0 | 3,168 | 0.45% | +3,168 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 5,107 | 6,752 | 0.96% | +1,645 |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | 6,900 | 6,167 | 0.87% | -733 |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | 54,179 | 37,754 | 5.34% | -16,425 |
| Mineralys Therapeutics Inc.(MLYS) | 2,113,933 | 1,563,966 | -549,967 | 80,160 | 56,756 | 8.03% | -23,404 |
| CRISPR Therapeutics AG(CRSP) | 2,038,763 | 2,038,763 | 0 | 132,132 | 106,913 | 15.14% | -25,219 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 192,658 | 153,000 | 21.66% | -39,658 |